advanced search

Welcome: Guest

log in

CNS Market Research

A concise collection of reports on CNS, data includes Drug Discoveries, Disorders, Prospects and Opportunities.

Stay up-to-date with new products added to this category
Title Date Price
The CNS Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
Sep 2008 £1,995
CNS Drug Discoveries: what the future holds 2008 FULL REPORT
Aug 2008 £1,795
MarketWatch: CNS
Aug 2008 £110
CNS Generic Drugs: Prospects and Opportunities to 2012
Apr 2008 £995
Commercial Insight: CNS Market Overview
Commercial dynamics and outlook of the neurology, pain and psychiatry market sectors
Apr 2008 £8,000
Central Nervous System Depression
Mar 2008 £800
Central Nervous System Migraine
Mar 2008 £800
Central Nervous System Multiple Sclerosis
Mar 2008 £800
Central Nervous System Pain
Mar 2008 £800
Central Nervous System Parkinson Disease
Mar 2008 £800
Central Nervous System Psychotic Disorders
Mar 2008 £800
Central Nervous System Schizophrenia
Mar 2008 £800
Central Nervous System Memory Impairment
Mar 2008 £800
Central Nervous System Insomnia or Sleep Disorders
Mar 2008 £800
Central Nervous System Headache
Mar 2008 £800
Central Nervous System Epilepsy
Mar 2008 £800
Central Nervous System Dementia
Mar 2008 £800
Central Nervous System Attention Deficit Disorder with Hyperactivity
Mar 2008 £800
Central Nervous System Anxiety
Mar 2008 £800
Central Nervous System Alzheimer Disease
Mar 2008 £800
Central Nervous System Seizures
Mar 2008 £800
Central Nervous System Stroke
Mar 2008 £800
Central Nervous System Neuropathy
Mar 2008 £800
Alzheimer's Disease Market analysis and forecasts, 2007-2012, 2017 & 2022
Oct 2007 £1,499
The CNS Market Outlook To 2012
Oct 2007 £1,495
Pipeline And Commercial Insight: Parkinson's Disease
Market To Grow As First Round Of Lifecycle Management Strategies Succeed
Sep 2007 £7,600
Commercial Insight: Epilepsy
Companies Committed To The Cause Will Reap The Benefits
Sep 2007 £7,600
Commercial Insight: Migraine
Opportunities Will Exist In The Wake Of Generic Attack
Sep 2007 £7,600
Pipeline Insight: Neuropathic Pain
Emerging Drugs Fail To Capitalize In Lucrative Market
Sep 2007 £6,000
CNS Market Trends, 2007 to 2010
Key Market Forecasts and Growth Opportunities
Jun 2007 £995
Neurodegenerative Disease Drug Market Analysis and Forecasts 2007
Jun 2007 £1,999
Pipeline Insight: Depression
Novel drugs to grow third-line market
Mar 2007 £6,000
Innovations in CNS
Novel therapeutics and future R&D strategies
Jan 2007 £1,495
Stakeholder Insight: Multiple Sclerosis
Disease-modifying efficacy and side effects guide treatment choice
Dec 2006 £8,000
Stakeholder Insight: Alzheimer's Disease
Prescribing trends indicate that neurologists are not adhering to guidelines
Dec 2006 £8,000
Pipeline Insight: Migraine
Innovation essential as weak late-stage pipeline fails to hold off the impact of triptan patent expiries
Dec 2006 £6,000
CNS Drug Discoveries: Sleep Disorders
Nov 2006 £795
CNS Drug Discoveries: Attention Deficit Hyperactivity Disorder (ADHD)
Nov 2006 £795
CNS Drug Discoveries: Neurodegenerative Disorders
Nov 2006 £795
CNS Drug Discoveries: Multiple Sclerosis
Nov 2006 £795
CNS Drug Discoveries: Depression
Nov 2006 £795
Pipeline Insight: Breakthrough Pain
Fast-acting players will capture majority market share
Nov 2006 £6,000
The CNS Market Outlook to 2011
Nov 2006 £1,495
Pipeline Insight: Epilepsy
Pipeline drugs struggle to outshine their marketed predecessors
Oct 2006 £6,000
Global Market for Sleep-Wake Disorders, 2005-2012, The
Trends, Opportunities, and Insights in a High-Value CNS Therapy Area
Dec 2005 £1,100

Industry Events

BioProduction 2008

28 Oct 08 to 29 Oct 08
Dusselfdorf, Germany
view summary >>

EuroTIDES

02 Dec 08 to 03 Dec 08
Düsseldorf, Germany
view summary >>

#